Release date: 29 December 2017
Promoter – Financial Intermediary
KLINICKI BOLNICKI CENTAR RIJEKALocation
Description
Development of the Rijeka General Hospital (KBCRi) on the Susak campus thereby facilitating the relocation and closure of the Rijeka and Kantrida sites. The project shall provide an integrated, efficient and complete hospital service offer in one central location and in close vicinity of Rijeka's university medical faculty that relies on the KBCRi as teaching hospital. The hospital's underlying strategic development plan is prepared by consultancy provided under the European Investment Advisory Hub (EIAH).
Objectives
Relocation of all hospital activities in one campus to provide an integrated, efficient and complete hospital service offer.
Sector(s)
- Health - Human health and social work activities
Proposed EIB finance (Approximate amount)
EUR 50 million
Total cost (Approximate amount)
EUR 117 million
Environmental aspects
Hospitals are not specifically mentioned in the Environmental Impact Assessment (EIA) Directive 2011/92/EU as amended, though the project is covered by Annex II of the directive in relation to urban development. The Bank's services will verify during appraisal the screening decision of the competent authority and whether an EIA is required. It is expected that the project will have positive social benefits as healthcare is an element of social cohesion.
Procurement
The Bank will require the promoter to ensure that contracts for the implementation of the project have been/shall be tendered in accordance with the relevant applicable EU procurement legislation (Directive 2004/18/EC and/or 2004/17/EC as well as Directives 89/665/EEC and 92/13/EEC) as interpreted by the Court of Justice of the EU, with publication of tender notices in the Official Journal of the EU, as and where required.
Status
Signed - 30/04/2019
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).